Literature DB >> 12186513

Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?.

Carlo Salvarani1, Mauro Silingardi, Angelo Ghirarduzzi, Giovanni Lo Scocco, PierLuigi Macchioni, GianLuigi Bajocchi, Marco Vinceti, Fabrizio Cantini, Ido Iori, Luigi Boiardi.   

Abstract

BACKGROUND: Evidence of a dark halo on ultrasonography has been considered a specific sign of giant-cell arteritis and may replace temporal artery biopsy for the diagnosis of giant-cell arteritis in patients with typical clinical manifestations.
OBJECTIVE: To assess the usefulness of temporal artery duplex ultrasonography and to compare this mode of ultrasonography with physical examination of temporal arteries for the diagnosis of giant-cell arteritis in patients with suspected giant-cell arteritis or polymyalgia rheumatica.
DESIGN: Diagnostic test study.
SETTING: Several divisions of Reggio Emilia Hospital, Reggio Emilia, Italy. PATIENTS: 86 consecutive patients with a suspected diagnosis of giant-cell arteritis or polymyalgia rheumatica identified over a 22-month period. MEASUREMENTS: The temporal arteries were examined in all 86 patients. Duplex ultrasonography of the temporal arteries was then performed by two ultrasonographers who were unaware of the clinical diagnosis. Before corticosteroid therapy was started, temporal artery biopsies were performed in all patients at the site targeted by the ultrasonographer.
RESULTS: A hypoechoic halo around the lumen of the temporal arteries had a sensitivity of only 40% (95% CI, 16% to 68%) and a specificity of 79% (CI, 68% to 88%) for the diagnosis of biopsy-proven giant-cell arteritis. The negative likelihood ratio was 0.8 (CI, 0.5 to 1.2), and the positive likelihood ratio was 1.9 (CI, 0.9 to 4.1). When the thickness of the halo was at least 1 mm, specificity increased to 93% (CI, 84% to 98%) and the positive likelihood ratio increased to 5.7 (CI, 2.0 to 16.2); however, sensitivity remained low at 40% (CI, 16% to 68%). On physical examination, temporal artery abnormalities had a higher sensitivity of 67% (CI, 38% to 88%), a higher specificity of 99% (CI, 92% to 100%), and a higher positive likelihood ratio of 47.3 (CI, 6.5 to 342.4) than did ultrasonographic findings. None of the patients with giant-cell arteritis had a normal temporal artery inspection and a hypoechoic halo on ultrasonography.
CONCLUSION: Evidence on ultrasonography of a halo around temporal arteries, either any halo or a halo 1 mm or greater in thickness, only modestly increased the probability of biopsy-proven giant-cell arteritis but did not improve the diagnostic accuracy of a careful physical examination.

Entities:  

Mesh:

Year:  2002        PMID: 12186513     DOI: 10.7326/0003-4819-137-4-200208200-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  42 in total

1.  Comment on Meller et al.: Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis.

Authors:  S Vanderschueren; I Buysschaert; L Mortelmans; D Blockmans; D C Knockaert
Journal:  Eur Radiol       Date:  2003-10-21       Impact factor: 5.315

2.  Color-coded sonography in suspected temporal arteritis-experiences after 83 cases.

Authors:  Matthias Reinhard; Dieter Schmidt; Andreas Hetzel
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

3.  Colour duplex ultrasonography in the management of giant cell arteritis.

Authors:  Giuseppe Nicoletti; Giovanni Ciancio; Salvatore Tardi; Ignazio Olivieri
Journal:  Clin Rheumatol       Date:  2003-11-05       Impact factor: 2.980

Review 4.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

5.  The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.

Authors:  Martin Fuchs; Matthias Briel; Thomas Daikeler; Ulrich A Walker; Helmut Rasch; Scott Berg; Quinn K T Ng; Heike Raatz; David Jayne; Ina Kötter; Daniel Blockmans; Maria C Cid; Sergio Prieto-González; Peter Lamprecht; Carlo Salvarani; Zaharenia Karageorgaki; Richard Watts; Raashid Luqmani; Jan Müller-Brand; Alan Tyndall; Martin A Walter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

6.  Follow-up vascular ultrasounds in patients with giant cell arteritis.

Authors:  Julia A Ford; Michael A DiIorio; Weixing Huang; Piotr Sobiesczcyk; William P Docken; Sara K Tedeschi
Journal:  Clin Exp Rheumatol       Date:  2020-04-27       Impact factor: 4.473

7.  Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis.

Authors:  A D Wagner; J Andresen; E Raum; J Lotz; H Zeidler; J G Kuipers; M C Jendro
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

8.  3-T MRI reveals cranial and thoracic inflammatory changes in giant cell arteritis.

Authors:  T A Bley; M Uhl; N Venhoff; J Thoden; M Langer; M Markl
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

9.  B-flow ultrasound in a case of giant cell arteritis.

Authors:  Alessandro Volpe; Paola Caramaschi; Antonio Marchetta; Domenico Biasi; Lisa Maria Bambara; Guido Arcaro
Journal:  Clin Rheumatol       Date:  2007-02-17       Impact factor: 2.980

10.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.